Dr. Andrew Craig

Director, Queen’s Cancer Research Institute
Professor, Department of Biomedical & Molecular Sciences
Queen’s University 

"Impacts of TGF-β inhibitors on improved chemotherapy and immunotherapy responses in preclinical models of ovarian cancer"  

Host: Dr. Rob Rottapel

In Person **at Princess Margaret Cancer Research Tower**
Room: PMCRT 4-204